Assuming diseases is required, the following 103 results were found.
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Zeng, Ph.D., a molecular biologist and principal investigator at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), is the recipient of the 2021-2022 Research and Development Award presented by AMSUS, the Society of Federal...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
protein aggregation and how these synthetic peptides work. Alzheimer’s and Type 2 diabetes are part of a family of amyloid diseases that are characterized by having proteins that cluster together. What’s happening? Valerie Daggett: There are over 50 of...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Medical News
-
treating a variety of health-related conditions that can be traced to environmental stressors. Topics include infectious diseases, non-communicable diseases, malnutrition, heat stress, physical trauma and mental health concerns. “We want the skills...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Medical News
-
team including Dr. Yu Kaku, Kaho Okumura and Dr. Jumpei Ito. The study, published in Volume 24 of The Lancet Infectious Diseases on January 03, 2024, sheds light on the variant’s potential to become the dominant lineage and alerts the global health...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
to U.S. Secretary of Defense Mark Esper regarding funding for the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and the U.S. Army Combat Capabilities Command (CCDC) Chemical Biological Center at Aberdeen Proving Ground. On...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
nations. Kugelman, who directs the Center for Genome Sciences at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Md., spent 2.5 years as a Science and Technology attaché under an exchange program for...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the only Biosafety Level 4 laboratory in the Department of Defense, has ceased research operations on high-risk pathogens after failing to meet Federal biosafety requirements....
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) will resume limited research, following a successful recent inspection by the Centers for Disease Control and Prevention (CDC). The announcement was made in on Nov. 22 in...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Late last week we learned, in an embarrassing turn of events, the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), had its research put on hold following a visit in June 2019 by the Center for Disease Control and Prevention (CDC),...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
treatments to combat emerging pathogens. Army scientists at the at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have developed the first lethal mouse model of SARS-CoV-2, the virus that causes COVID-19. The model utilizes...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
The U.S. Army for Medical Research Institute of Infectious Diseases (USAMRIID) has suspended Biosafety Level 3 (BSL-3) and Biosafety Level 4 (BSL-4) operations while conducting repairs to its waste treatment plant. Unprecedented heavy rainfall in the...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
on Feb. 6 the results of a successful Phase 3 clinical trial led by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) that demonstrated the safety and efficacy of the company’s investigational, non-replicating smallpox vaccine,...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pycnogonida (PHAGE VIRUS)
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.